☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Kyowa Annouces P-IIa Results of KW-6356 for Parkinson's Disorder at IAPRD
August 21, 2018
Harbour Annouces Global Partnership with Kelun-Biotech to Develop and Commercialize A167 (Anti-PD-L1 mAb)
August 21, 2018
Roche's Alecensa® (alectinib) Receives CFDA Priority Review for 1L ALK +ve mNSCLC
August 21, 2018
Merck's Keytruda (pembrolizumab) Receives Expanded Label Approval for 1L nonsq. mNSCLC- with No EGFR and ALK Genomic Tumor
August 21, 2018
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions